Effect of intracoronary Adenosine infusion during primary percutaneous coronary intervention in Acute Myocardial infarctio
Phase 3
Recruiting
- Conditions
- Acute myocardial infarction.Ischaemic heart diseases
- Registration Number
- IRCT2017062434621N1
- Lead Sponsor
- Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
(a) ST elevation MI in ECG; (b) LAD and LCX lesion; (c) coronary lesion suitable for angioplasty; (d) TIMI flow 0-1.
Exclusion criteria: (a) history of COPD or asthma; (b) patients who under treatment with dipyridamol; (c) Presentation with cardiogenic shock; (d) Patients who received fibrynolytic; (e) life expectancy less than 6 month; (f) stent thrombosis; (g) history of CABGs; (h) AV nodal block in first ECG; (I) TIMI flow 2-3 in angiography; (j) RCA lesion; (k) lack of patient satisfaction.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ST elevation resolution. Timepoint: Before and after intervention. Method of measurement: ECG.;TIMI flow. Timepoint: Before and after intervention. Method of measurement: Angioplasty.;Level of CKMB and troponin. Timepoint: Before and after intervention. Method of measurement: Blood sample.
- Secondary Outcome Measures
Name Time Method Inhospital mortality. Timepoint: After intervention. Method of measurement: check list.;Duration of hospitalization. Timepoint: After intervention. Method of measurement: check list.;Hemodynamic stability. Timepoint: After intervention. Method of measurement: check list.;Electrical stability. Timepoint: After intervention. Method of measurement: ECG.;Left ventricular ejection fraction. Timepoint: After intervention. Method of measurement: Echocardiography.